Statera Biopharma, Inc. Annual Operating Income (Loss) in USD from 2010 to 2021

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Statera Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2021.
  • Statera Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$1.55M, a 84% increase year-over-year.
  • Statera Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$88.2M, a 261% decline year-over-year.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$98.3M, a 836% decline from 2020.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2020 was -$10.5M, a 345% decline from 2019.
  • Statera Biopharma, Inc. annual Operating Income (Loss) for 2019 was -$2.36M, a 50.8% increase from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.